Explore our library of archived lectures on immunotherapy from The Science of Childhood Cancer hosted by the St. Jude Comprehensive Cancer Center. Please register for updates on upcoming virtual events.
![Science of Childhood Cancer logo](/content/sites/www/en_US/home/education-training/advanced-training/seminars-symposia/science-of-childhood-cancer-series/archive-category/immunotherapy-category/jcr:content/par-1/cnt_row/par-1/cnt_aside_566334181/par-1/cnt_image_copy.img.16.medium.png/1595541656431.png)
Explore other lecture topics
Immunotherapy lectures
-
Engineered Cell Therapy for Pediatric Cancer
08/08/2024
Stephen Gottschalk, MD
Chair, Department of Bone Marrow Transplantation and Cellular Therapy
Co-Director, Center of Excellence for Pediatric Immuno-Oncology
St. Jude Children's Research Hospital -
Targeting metabolic vulnerabilities in high-risk childhood cancer using immunotherapy (and other modalities)
04/11/2024
Poul Sorensen, BSc, MD, PhD, FRCPC
The University of British Columbia -
Neuroblastoma: The power of immunotherapy in pediatric malignancy
11/02/2023
Julie Park, MD
St. Jude Children's Research Hospital -
Sounding an alarm: Innate immunity makes cancer immunogenic
08/31/2023
Judy Lieberman, MD, PhD
Boston Children's Hospital
Harvard Medical School -
Translating the self/nonself discrimination problem in cancer
08/24/2023
Benjamin Greenbaum, PhD
Memorial Sloan Kettering Cancer Center
Weill Cornell Medicine -
Emerging Therapies for Pediatric Leukemia
05/04/2023
Sarah K Tasian, MD
University of Pennsylvania School of Medicine
Children’s Hospital of Philadelphia -
Rising Stars of Cancer Research
03/23/2023
CAR T-cells for T-cell Malignancies: Proving and Improving
Maksim Mamonkin, PhD
Baylor College of Medicine
What Will it Take to Make CARTs Effective for Pediatric Brain Tumors?
Giedre Krenciute
St. Jude Children's Research Hospital -
Rising Stars of Cancer Research
11/10/2022
Co-opting the TCR Machinery to Enhance CAR T Cell Efficacy and Specificity
Robbie Majzner
Stanford
The Evolution of Pediatric Gliomas
Pratiti (Mimi) Bandopadhayay
Dana-Farber/Boston -
Designing and Developing Pediatric Cancer-Specific Immunotherapies
09/08/2022
John M. Maris, MD
Perelman School of Medicine
University of Pennsylvania -
Engineered T cells for Cancer Therapy
08/11/2022
Carl H. June, MD
Perelman School of Medicine, University of Pennsylvania -
Functional Genomics of T-Cell Metabolism and Immuno-oncology
03/10/2022
Hongbo Chi, PhD
St. Jude Children's Research Hospital -
CAR T Cell Therapies for Childhood Cancer, the University College London Experience
10/28/2021
Martin Pule, MB, FRCPath
University College London -
Chimeric Antigen Receptor-Redirected Macrophages for the Treatment of Solid Tumors
10/07/2021
Saar Gill, MBBS, PhD, FRACP
University of Pennsylvania Perelman School of Medicine -
Organized Destruction and Destructive Organization: The Diversity of Immune Responses Towards Tumors and Pathogens
11/05/2020
Paul G. Thomas, PhD
St. Jude Children's Research Hospital -
The Future of CAR T Cells for Hematologic Malignancies: Beyond Antigen Targeting Beyond Antigen Targeting
08/27/2020
Terry J. Fry, MD
University of Colorado School of Medicine
Children’s Hospital Colorado, Center for Cancer and Blood Disorders -
CAR T Cells: On the Road to Synthetic Immunity
08/13/2020
Michel Sadelain, MD, PhD
Memorial Sloan-Kettering Cancer Center
Comprehensive Cancer Center
St. Jude is the first and only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children.
![](/content/sites/www/en_US/home/education-training/advanced-training/seminars-symposia/science-of-childhood-cancer-series/archive-category/immunotherapy-category/jcr:content/par-1/cnt_row_1235823634_c.img.16.medium.jpg/1620226575938.jpg)